Drug Discovery in Hematology

Advancing novel therapeutic agents for the treatment of malignancy into the marketplace is an increasingly costly and lengthy process. As such, new strategies for drug discovery are needed. Drug repurposing represents an opportunity to rapidly advance new therapeutic strategies into clinical trials at a relatively low cost. Known on-patent or off-patent drugs with unrecognized anticancer activity can be rapidly advanced into clinical testing for this new indication by leveraging their known pharmacology, pharmacokinetics and toxicology. Using this approach, academic groups can participate in the drug discovery field and smaller biotechnology companies early-stage drug discovery projects. Here, several scientific approaches used to identify drug repurposing opportunities are highlighted with a focus on hematologic malignancies. In addition a discussion of the regulatory issues that are unique to drug repurposing and how they impact developing old drugs for new indications is included. Finally, the mechanisms to enhance drug repurposing through increased collaborations between academia, industry and nonprofit charitable organizations are discussed.

  • Biological Drugs
  • Generic Drugs
  • Cancer Pharmaceutical Companies

Related Conference of Drug Discovery in Hematology

September 03-05, 2018

4th International Congress on Epigenetics & Chromatin

London, UK (Park Inn by Radisson London Heathrow)
September 5-6, 2018

15th Asia Pacific
Oncologists Annual Meeting

Tokyo, Japan
September 17-18, 2018

International Conference on Oncogenesis and Oncologic Emergency Medicine

San Diego, California, USA
September 17-18, 2018

28th International Conference on Cancer Research and Anticancer Therapies

San Diego, California, USA
September 24-25, 2018

3rd World Conference on Breast and Cervical Cancer

Abu Dhabi, UAE
October 03-04, 2018

10th Annual Congress on Biomarkers, Clinical Research
& Therapeutics

Los Angeles, California, USA
October 15-16, 2018

22nd World Conference onLiquid Biopsy & Biomarkers

Toronto, Canada
October 18-19, 2018

Euro Oncology Summit

| Amsterdam, Netherlands
October 18-19, 2018

14th Global Biomarkers Summit

| Amsterdam, Netherlands
October 18-19, 2018

9th Euro Breast Cancer Summit

| Amsterdam, Netherlands
October 11-13, 2018

36th World Cancer Conference

Venue: Hilton Zurich Airport, Hohenbühlstrasse 10, 8152 Opfikon, Switzerland
October 26-27, 2018

International Conference on Robotic Oncology

Osaka, Japan
October 29-30, 2018

International Conference on Gastrointestinal Cancer and Therapeutics

San Francisco, California, USA
October 29-30, 2018

26th Annual Congress on Cancer Science and Targeted Therapies

San Francisco, California, USA
November 14-15, 2018

International Conference on Cancer Science & Robotics

Melbourne, Australia
November 14-15, 2018

30th Experts Meet On Cancer Therapy

Melbourne, Australia
November 29-30, 2018

13th World Biomarkers Congress

Dublin, Ireland
November 29-December 01, 2018

3rd Cancer Diagnostics & Treatment Conference

Dublin, Ireland
March 07-08, 2019

32nd Euro Congress on Cancer Science & Therapy

Barcelona, Spain
April 1-3, 2019

21st World Congress on Pediatric & Neonatal Oncology

Auckland, New Zealand
April 04-05, 2019

23rd Global Annual Oncologists Meeting

Auckland, New Zealand
April 8-9, 2019

3 rd World Congress on Radiology and Oncology

Abu, Dhabi, UAE
April 29-30, 2019

Global Experts Meeting onCancer Science & Therapy

Seoul, South Korea
May 6-7, 2019

3rd Global Summit on Oncology & Cancer

Tokyo, Japan
May 09-10, 2019

15th World Congress on Blood Cancer

Amsterdam, Netherlands

Drug Discovery in Hematology Conference Speakers

Recommended Sessions

Related Journals

Are you interested in